Hypofractionation for prostate cancer: a word of caution

被引：3

作者：

Bossi, Alberto ^{[1
]}

Blanchard, Pierre ^{[1
]}

机构：

[1] Gustave Roussy Canc Ctr, Dept Radiat Oncol, Villejuif, France

来源：

LANCET ONCOLOGY | 2016年 / 17卷 / 04期

关键词：

CONVENTIONALLY FRACTIONATED RADIOTHERAPY; NON-INFERIORITY;

D O I：

10.1016/S1470-2045(15)00626-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：406 / 407

页数：3

共 7 条

[1]

Aluwini S, 2016, LANCET ONCOL

[2] Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial [J].

Aluwini, Shafak ;

Pos, Floris ;

Schimmel, Erik ;

van Lin, Emile ;

Krol, Stijn ;

van der Toorn, Peter Paul ;

de Jager, Hanja ;

Dirkx, Maarten ;

Alemayehu, Wendimagegn Ghidey ;

Heijmen, Ben ;

Incrocci, Luca .

LANCET ONCOLOGY, 2015, 16 (03) :274-283

[3] Prostate alpha/beta revisited - an analysis of clinical results from 14 168 patients [J].

Dasu, Alexandru ;

Toma-Dasu, Iuliana .

ACTA ONCOLOGICA, 2012, 51 (08) :963-974

[4]

Incrocci L, 2016, INT J RADIAT ONCOL, V94, P1

[5] A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer [J].

Koontz, Bridget F. ;

Bossi, Alberto ;

Cozzarini, Cesare ;

Wiegel, Thomas ;

D'Amico, Anthony .

EUROPEAN UROLOGY, 2015, 68 (04) :683-691

[6] NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer [J].

Lee, W. R. ;

Dignam, J. J. ;

Amin, M. ;

Bruner, D. ;

Low, D. ;

Swanson, G. P. ;

Shah, A. B. ;

D'Souza, D. P. ;

Michalski, J. M. ;

Dayes, I. S. ;

Seaward, S. A. ;

Hall, W. A. ;

Nguyen, P. L. ;

Pisansky, T. M. ;

Faria, S. ;

Chen, Y. ;

Koontz, B. F. ;

Paulus, R. ;

Sandler, H. M. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01) :3-4

[7] Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial [J].

Wilkins, Anna ;

Mossop, Helen ;

Syndikus, Isabel ;

Khoo, Vincent ;

Bloomfield, David ;

Parker, Chris ;

Logue, John ;

Scrase, Christopher ;

Patterson, Helen ;

Birtle, Alison ;

Staffurth, John ;

Malik, Zafar ;

Panades, Miguel ;

Eswar, Chinnamani ;

Graham, John ;

Russell, Martin ;

Kirkbride, Peter ;

O'Sullivan, Joe M. ;

Gao, Annie ;

Cruickshank, Clare ;

Griffin, Clare ;

Dearnaley, David ;

Hall, Emma .

LANCET ONCOLOGY, 2015, 16 (16) :1605-1616

← 1 →